Tag: harbor

Financial and Operating Highlights

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced it has signed a new 64,077 square foot lease with Sigma Computing, Inc. for a portion of the 3^rd floor at One Madison Avenue, bringing the property to 78.1% leased. To date in 2025, SL Green has signed Manhattan office leases totaling 1,260,707 square feet, while maintaining a current pipeline of approximately 1.0 million square feet.

NORTH BERGEN, NJ, July 16, 2025 (GLOBE NEWSWIRE) -- Free Flow, Inc. (OTC PK: FFLO), which is incorporated in the state of Delaware as Free Flow USA, Inc., today announced that the Company’s Accurate Investments, Inc subsidiary has entered into a contract to purchase a real estate investment property in New Jersey with existing and arranged highly-accredited tenants that would pay an approximate triple net lease amount of over $1,800,000 per annum against long term leases.

TEL AVIV, Israel, July 16, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, "the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, today announced it will release its financial results for the second quarter ended June 30, 2025, before market open on Wednesday, August 6, 2025.

DALLAS, July 15, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX), the parent holding company for Veritex Community Bank, today announced a date change for release of its second quarter 2025 earnings results. Veritex will now release its second quarter 2025 earnings results before the opening of the market on Friday, July 18, 2025. The earnings release will be available on Veritex’s website, https://ir.veritexbank.com/.

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) today announced that it has acquired the remaining 50% ownership interest in Constructive Loans, LLC (“Constructive”), a leading originator in business purpose loans for residential real estate investors. This all-cash transaction, completed through a wholly owned subsidiary of the Company, represents a significant milestone in the Company’s ongoing strategy to diversify and scale its recurring earnings through the inclusion of a top operating platform.

BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase common stock in an underwritten public offering. Gain expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock and/or the warrants offered in the offering. All of the securities are being offered by the Company.